141120-33-4

Basic information

• Product Name: 1,4-DIOXASPIRO[4.5]DECAN-8-YL METHANESULFONATE
• Synonyms: 1,4-DIOXASPIRO[4.5]DECAN-8-YL METHANESULFONATE;1,4-Dioxa-spiro[4.5]dec-8-yl methanesulfonate, 98%
• CAS NO: 141120-33-4
• Molecular Formula: C₉H₁₆O₅S
• Molecular Weight: 236.29
• Mol File: 141120-33-4.mol
• Article Data: 30

Chemical Properties

• Boiling Point: 398.624°C at 760 mmHg
• Flash Point: 194.881°C
• Appearance: /
• Density: 1.315g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.509
• CAS DataBase Reference: 1,4-DIOXASPIRO[4.5]DECAN-8-YL METHANESULFONATE(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-DIOXASPIRO[4.5]DECAN-8-YL METHANESULFONATE(141120-33-4)
• EPA Substance Registry System: 1,4-DIOXASPIRO[4.5]DECAN-8-YL METHANESULFONATE(141120-33-4)

Safety Data

• Hazardous Substances Data: 141120-33-4(Hazardous Substances Data)

Usage

Chemical structure

1,4-dioxaspiro[4.5]decan-8-yl methanesulfonate

Type of compound

Sulfonate ester

Derived from

1,4-dioxaspiro[4.5]decan-8-ol

Common use

Pharmaceutical intermediate in the synthesis of various medications

Known for

Stabilizing and protecting drugs by preventing degradation and improving shelf life

Utilized as

Blocking agent for the protection of hydroxy and amino groups in organic synthesis

Applications

Pharmaceutical and chemical industries

Versatility

Wide range of applications in both industries due to its protective and stabilizing properties

InChI:InChI=1/C9H16O5S/c1-15(10,11)14-8-2-4-9(5-3-8)12-6-7-13-9/h8H,2-7H2,1H3

Upstream product

• 22428-87-1 4,4-ethylenedioxycyclohexan-1-ol 
• 124-63-0 methanesulfonyl chloride 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 73223-83-3 1,4-dioxaspiro[4,5]decan-9-ol 

Downstream Products

• 7092-24-2 1,4-dioxaspiro<4.5>dec-7-ene 
• 286441-64-3 8-(4-chlorobenzylthio)-1,4-dioxaspiro[4.5]decane 
• 183801-42-5 4-(4-chlorobenzylthio)cyclohexanone 
• 183801-05-0 1-(4-chlorobenzylthio)-4-(methoxymethylene)cyclohexane 
• 183801-07-2 trans-4-(4-chlorobenzylthio)cyclohexanecarbaldehyde 
• 183801-12-9 S-[trans-4-[(1E,3E)-4-[4-(trifluoromethyl)phenyl]-1,3-butadienyl]cyclohexyl] thioacetate 
• 183801-09-4 trans-1-(4-chlorobenzylthio)-4-[(1E,3E)-4-[4-(trifluoromethyl)phenyl]-1,3-butadienyl]cyclohexane 
• 141269-53-6 (+/-)-(5β,7α,8β)-3,4-dichloro-N-methyl-N-<3-methylene-2-oxo-8-(1-pyrrolidinyl)-1-oxaspiro<4,5>dec-7-yl>benzeneacetamide 
• 141269-53-6 (+/-)-(5α,7α,8β)-3,4-dichloro-N-methyl-N-<3-methylene-2-oxo-8-(1-pyrrolidinyl)-1-oxaspiro<4,5>dec-7-yl>benzeneacetamide 
• 919099-98-2 8-[4-(trifluoromethyl)phenylthio]-1,4-dioxa-spiro[4.5]decane 
• 1046137-43-2 4-[(3-chloro-2-fluoro-phenyl)amino]-6-(1,4-dioxa-spiro[4.5]decan-8-yl-oxy)-7-methoxy-quinazoline 
• 1046452-35-0 3-benzyl-3,4-dihydro-4-oxo-6-(1,4-dioxa-spiro[4,5]decan-8-yl-oxy)-7-methoxy-quinazoline 
• 78847-53-7 4-oxocyclohexyl methanesulfonate 
• 1046137-42-1 4-[(3-chloro-2-fluoro-phenyl)amino]-6-(4-oxo-cyclohexyloxy)-7-methoxy-quinazoline 

Relevant articles and documents

Synthesis of 1-substituted epibatidine analogues and their in vitro and in vivo evaluation as α4β2 nicotinic acetylcholine receptor ligands

The highly potent natural alkaloid epibatidine remains a source of inspiration in the search for new analgesic drugs. In this paper, we describe an expansion of our previously reported synthesis of epibatidine analogues, and five synthetic alkaloids chara

3-(dimethylaminomethyl) cyclohex-4-alcohol derivative as well as preparation method and pharmaceutical application thereof

The invention belongs to the field of pharmacy, and relates to a 3-(dimethylaminomethyl) cyclohex-4-alcohol derivative with a general formula (I) or a salt thereof and a preparation method, and relates to an application of the compound in treatment of opioid receptor mediated diseases. The present invention provides a pharmaceutically acceptable solvate or hydrate of a compound of formula (I), and also provides a pharmaceutical composition comprising: a compound of formula (I) or a pharmaceutically acceptable salt, solvate or hydrate thereof; and a pharmaceutically acceptable carrier. The medicine prepared from the compound can be used for treating or improving diseases related to an opioid receptor; wherein the diseases can be selected from but not limited to pain, gastrointestinal diseases and depression.

BENZAMIDES OF PYRAZOLYL-AMINO-PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF

Provided is a novel class of orally and/or topically available, selective and potent JAK inhibitors as safe and effective therapeutics against various diseases and disorders. More particularly, provided are pharmaceutical composition of these compounds and methods of their preparation and use thereof.